Effect of Systemic Infliximab Therapy in Patients with Sjogren's Syndrome


Creative Commons License

TÜRKOĞLU ŞEN E. B., TUNA S., ALAN S., Arman M. I., Tuna Y., ÜNAL M.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, cilt.45, sa.4, ss.138-141, 2015 (ESCI) identifier identifier identifier

Özet

Objectives: To investigate the effect of systemic infliximab therapy on tear function tests and the ocular surface in patients with Sjogren's syndrome secondary to various autoimmune diseases.